NO20012262L - Urin¶r trypsin-inhibitoranalyse inneholdende et chelaterende middel - Google Patents

Urin¶r trypsin-inhibitoranalyse inneholdende et chelaterende middel

Info

Publication number
NO20012262L
NO20012262L NO20012262A NO20012262A NO20012262L NO 20012262 L NO20012262 L NO 20012262L NO 20012262 A NO20012262 A NO 20012262A NO 20012262 A NO20012262 A NO 20012262A NO 20012262 L NO20012262 L NO 20012262L
Authority
NO
Norway
Prior art keywords
chelating agent
trypsin inhibitor
assay
assay containing
inhibitor assay
Prior art date
Application number
NO20012262A
Other languages
English (en)
Other versions
NO20012262D0 (no
Inventor
Gary E Rehm
Michael J Pugia
Paul F Corey
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of NO20012262D0 publication Critical patent/NO20012262D0/no
Publication of NO20012262L publication Critical patent/NO20012262L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/81—Protease inhibitors
    • G01N2333/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • G01N2333/811—Serine protease (E.C. 3.4.21) inhibitors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/976—Trypsin; Chymotrypsin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20012262A 2000-05-15 2001-05-08 Urin¶r trypsin-inhibitoranalyse inneholdende et chelaterende middel NO20012262L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US20403200P 2000-05-15 2000-05-15

Publications (2)

Publication Number Publication Date
NO20012262D0 NO20012262D0 (no) 2001-05-08
NO20012262L true NO20012262L (no) 2001-11-16

Family

ID=22756329

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20012262A NO20012262L (no) 2000-05-15 2001-05-08 Urin¶r trypsin-inhibitoranalyse inneholdende et chelaterende middel

Country Status (13)

Country Link
US (1) US7001737B2 (no)
EP (1) EP1156121B1 (no)
JP (1) JP4699631B2 (no)
AT (1) ATE323175T1 (no)
AU (1) AU2650601A (no)
CA (1) CA2334321A1 (no)
DE (1) DE60118651T2 (no)
DK (1) DK1156121T3 (no)
ES (1) ES2262569T3 (no)
IL (1) IL140994A (no)
NO (1) NO20012262L (no)
PT (1) PT1156121E (no)
ZA (1) ZA200102449B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005040222A1 (en) * 2003-10-16 2005-05-06 Bayer Healthcare Llc Monoclonal antibodies for detection of urinary trypsin inhibitors
EP2160478B1 (en) * 2007-06-06 2014-08-27 Siemens Healthcare Diagnostics Inc. Predictive diagnostics for kidney disease
US20150369747A1 (en) 2011-07-15 2015-12-24 Siemens Healthcare Diagnostics Inc. Device and method for detection of humidity-compromised urine test strips
DK2733217T3 (en) 2009-01-26 2016-08-01 Siemens Healthcare Diagnostics Inc A method of detecting moisture-damaged urine test strips

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1254119A (en) * 1984-07-20 1989-05-16 Lloyd A. Schick Single step protease inhibitor assay
US5384247A (en) * 1987-04-10 1995-01-24 Boehringer Mannheim, Gmbh Determination of sodium ions in fluids
ATE225509T1 (de) * 1987-04-27 2002-10-15 Inverness Medical Switzerland Testgerät zur durchführung von spezifischen bindungsprüfungen
US5618684A (en) * 1992-02-07 1997-04-08 Oriental Yeast Co., Ltd. Method of determination of calcium
US5595731A (en) * 1994-03-21 1997-01-21 Vallieres; Lucien Organic fluid gelifying compounds
US6255091B1 (en) * 1995-04-28 2001-07-03 Axys Pharmaceuticals, Inc. Potentiating metal mediated serine protease inhibitors with cobalt or zinc ions
HU226419B1 (en) * 1996-03-11 2008-12-29 Aerovance Human bikunin
EP0814167A1 (en) * 1996-06-21 1997-12-29 Kabushiki Kaisha Kyoto Daiichi Kagaku A method for measuring the concentration of protease inhibitors, kit for use in such a method and method for dissolving a sunstrate
JPH1070997A (ja) * 1996-06-21 1998-03-17 Kdk Corp タンパク質分解酵素阻害物質の測定方法およびそれに用いる測定キット並びに基質の溶解方法
JP3626982B2 (ja) * 1997-08-29 2005-03-09 アークレイ株式会社 タンパク質分解酵素阻害物質の測定方法およびそれに用いる測定キット
JPH1183849A (ja) * 1997-09-12 1999-03-26 Toa Medical Electronics Co Ltd 尿中有形成分の分析方法及びその分析試薬
JPH11164699A (ja) * 1997-12-05 1999-06-22 Kdk Corp トリプシンの安定化方法およびトリプシンの酵素活性向上方法並びにトリプシン酵素活性測定用キット
WO1999049076A1 (fr) * 1998-03-20 1999-09-30 Arkray, Inc. Methode de dosage d'un inhibiteur de trypsine dans l'urine et trousse de dosage afferente
JP3059433B2 (ja) * 1998-03-20 2000-07-04 株式会社京都第一科学 尿中トリプシンインヒビタ―の測定方法およびそれに用いる測定キット

Also Published As

Publication number Publication date
NO20012262D0 (no) 2001-05-08
DE60118651T2 (de) 2007-04-05
JP4699631B2 (ja) 2011-06-15
IL140994A0 (en) 2002-02-10
EP1156121B1 (en) 2006-04-12
US7001737B2 (en) 2006-02-21
DK1156121T3 (da) 2006-07-31
ES2262569T3 (es) 2006-12-01
EP1156121A2 (en) 2001-11-21
DE60118651D1 (de) 2006-05-24
JP2002014096A (ja) 2002-01-18
ZA200102449B (en) 2001-09-28
ATE323175T1 (de) 2006-04-15
EP1156121A3 (en) 2004-01-14
AU2650601A (en) 2002-07-25
US20010055816A1 (en) 2001-12-27
PT1156121E (pt) 2006-07-31
CA2334321A1 (en) 2001-11-15
IL140994A (en) 2005-12-18

Similar Documents

Publication Publication Date Title
GB2337328A (en) Method and apparatus for rapid hygiene testing
DK156730C (da) Testkomposition og -materiale til bestemmelse af tilstedevaerelsen af glucose i en flydende proeve samt fremgangsmaade til semikvantitativ bestemmelse af glucose i urin
ES2159379T3 (es) Programador quimico para una tira de ensayo visual.
GR3036073T3 (en) Analytical test apparatus with on board negative and positive control.
FR2832507B1 (fr) Methode de detection d'analyte(s) a l'aide de particules magnetiques colloidales
ATE285074T1 (de) Assay-vorrichtung
NO20012262D0 (no) Urin¶r trypsin-inhibitoranalyse inneholdende et chelaterende middel
ATE438098T1 (de) Teststreifen enthaltend kontrollmittel und zeitsetzermittel
DE60127309D1 (de) Analysegerät für biologische flüssigkeiten
ATE162628T1 (de) Verbesserter teststreifen
DE60310012D1 (de) Verfahren, Assay und Kit zur Quantifizierung von HIV-Proteasehemmer
ATE470148T1 (de) Verfahren zum vorbehandeln einer probe
DE59907982D1 (de) Verfahren zum Nachweis einer bei Apoptose aktivierten Protease
DE60131281D1 (de) Verfahren zum messen von gesamt-homocystein
DK555584A (da) Fremgangsmaade til specifik bestemmelse af pankreas-alfa-amylase vedsiden af spyt-alfa-amylase og reagens til brug ved udfoerelse af fremgangsmaaden
ATE114822T1 (de) Reagens zum nachweis von bilirubin in urin.
AU2836299A (en) Use of 14-3-3 proteins as sensitive biological markers for detecting pollution caused, inter alia, by polychlorinated biphenyl (pcb) and (xeno)oestrogen and method for quick determination of 14-3-3 proteins
AU7825500A (en) Inhibition enzyme linked immunosorbent assay (iELISA) for the detection and quantification of antibodies in biological samples
ATE322687T1 (de) Nachweis von prostatakrebs durch bestimmen des verhältnisses von psa zu igf-1
ATE274702T1 (de) Verwendung derivatisierter reagenzien in chemilumineszenz- und elektrochemilumineszenz- nachweisverfahren
NZ509904A (en) Detection of trypsin inhibitor in urine using a dry assay device having trypsin, buffer, a trypsin substrate and a chelating agent in an absorbent pad
DE59811370D1 (de) Verfahren zum Nachweis und zur Bestimmung enzymatischer Reaktionen in Urin
MY104675A (en) Chromogenic substrate for esterase and immunoassay using same.
GB2312289A (en) Biochemical sensor & novel media for bioelectrochemical reactions
ES2156528B1 (es) Procedimiento para la medicion en continuo de microorganismos vivos en liquidos.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application